Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes

Table 1

The result of robust gene model in TCGA - BLCA.

Seq	Order	Gene	nloglik	AIC	Selected
1	0	0	854.81	1709.62
1	1	GBP2	841.69	1685.39
1	2	TNFRSF14	837.46	1678.91
1	3	APOL2	836.23	1678.46
1	4	CLEC2D	832.52	1673.03
1	5	GSDMB	830.87	1671.74
1	6	CXorf38	830.68	1673.36
1	7	OAS1	830.35	1674.71
1	8	PSMB10	830.35	1676.7
1	9	OFD1	830.33	1678.66
1	10	RNF19A	828.15	1676.3
1	11	ECHDC2	828.15	1678.3
1	12	CD96	827.61	1679.23
1	13	DOCK8	827.29	1680.59
1	14	CARD8	826.8	1681.59
1	15	ALPK1	826.8	1683.59
1	16	TMEM229B	826.54	1685.08
1	17	ANAPC4	826.52	1687.03
1	18	PCED1B	825.94	1687.88
1	19	TRIM38	825.86	1689.72

Nloglik: negative log-likelihood; AIC: Akaike information criterion score.